Key result
Black race linked to ~34% lower NT-proBNP levels compared with White race.
Why the study?
The presence and interpretation of racial and ethnic differences in circulating NT-proBNP are controversial.
Does Black or Mexican American race/ethnicity reduce NT-proBNP levels in US adults without cardiovascular disease?
Cross-Sectional (n=8,540)
Does Black or Mexican American race/ethnicity reduce NT-proBNP levels in US adults without cardiovascular disease?
Effect estimate: 34.4% lower (95% CI -39.2 to -29.3%)
p-value: p=<0.001
Black and Mexican American adults have significantly lower baseline NT-proBNP levels compared to White adults independent of cardiometabolic risk, suggesting that race-agnostic cut-points for heart failure screening must be clinically contextualized.
Supports race-adjusted NT-proBNP thresholds for HF screening; leaves open effects on diagnostic accuracy and outcomes.
Background: The presence and interpretation of racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP), a diagnostic biomarker for heart failure, are controversial. Objective: To examine racial and ethnic differences in NT-proBNP levels among the general US adult population. Methods: We performed a cross-sectional analysis of data from the 1999-2004 National Health and Nutrition Examination Survey (NHANES). We included 4717 non-Hispanic White, 1675 non-Hispanic Black, and 2148 Mexican American adults aged 20 years or older without a history of cardiovascular disease. We examined the associations of race and ethnicity with NT-proBNP using linear and logistic regression models in the overall population and in a younger, 'healthy' subsample. Results: <0.001). After adjusting for sociodemographic factors and cardiovascular risk factors, NT-proBNP was 34.4% lower (95%CI -39.2 to -29.3%) in Black adults and 22.8% lower (95%CI -29.4 to -15.5) in Mexican American adults compared to White adults. Our findings were consistent in a young, healthy subsample, suggesting non-cardiometabolic determinants of these differences. Conclusions: NT-proBNP levels are significantly lower among Black and Mexican American adults compared with White adults, independent of cardiometabolic risk. Although race/ethnicity is a poor proxy for genetic differences, our findings may have clinical implications for the management of HF. However, studies in diverse populations are needed to characterize the biological basis of NT-proBNP variation.
No takes yet. Share an insight, caveat, or question.
Commodore‐Mensah et al. (2023) conducted a cross-sectional in Healthy (No cardiovascular disease) (n=8,540). Black or Mexican American race/ethnicity vs. White race/ethnicity was evaluated on NT-proBNP level (34.4% lower, 95% CI -39.2 to -29.3%, p=<0.001). Black adults had a 34.4% lower and Mexican American adults had a 22.8% lower NT-proBNP level compared to White adults, independent of sociodemographic and cardiovascular risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: